ARCHIVES

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

September 3, 1976

Coffey Presses NCI BSA chairman David Linvingston On support For Increase In NCI Budget

April 25, 1997

Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years

September 28, 2012

FDA Simplifies Reporting Of Adverse Events

June 18, 1993

Rhoads Presses For Greater Emphasis On Etiology In DNCP; Workshops Develop New Research Leads

July 16, 1976

HHS System Of Misconduct investigation Not Suited For Clinical Trials, Broder Says

November 11, 1994